Analysts think ACHV stock price could increase by 260%
Jun 11, 2025, 11:25 AM
-39.13%
What does ACHV do
Achieve Life Sciences, based in Seattle, is developing cytisinicline, a plant-based alkaloid, for smoking cessation and nicotine addiction, targeting cravings and withdrawal symptoms. The company employs 22 full-time staff.
8 analysts think ACHV stock price will increase by 260.33%. The current median analyst target is $13.26 compared to a current stock price of $3.68. The lowest analysts target is $10.10 and the highest analyst target is $21.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
